Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Odense University Hospital.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Odense University Hospital
Information provided by:
Odense University Hospital
ClinicalTrials.gov Identifier:
NCT00700024
First received: June 16, 2008
Last updated: September 18, 2009
Last verified: September 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the effect of training and testim on Hypogonadism.
| Condition | Intervention | Phase |
|---|---|---|
|
Hypogonadism Metabolic Syndrome |
Drug: Testim Behavioral: Strength training Drug: placebo |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | The Effect of Testim and Training in a Population Based, Randomized, Placebo-controlled, Double-blinded Study of Hypogonadal Men |
Resource links provided by NLM:
Drug Information available for:
Testosterone propionate
Methyltestosterone
Testosterone cypionate
Testosterone
Testosterone enanthate
U.S. FDA Resources
Further study details as provided by Odense University Hospital:
Primary Outcome Measures:
- Lean body mass [ Time Frame: january 2008-january 2010 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Insulin sensitivity, Visceral fat/liver fat, Body fat, Waist, Physical conditions and physical strengths, Adiponectin, Lipid metabolism, Subjective sensation of energy, Urine cortisol, Sexual function, Serum testosterone [ Time Frame: january 2008-january 2010 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 60 |
| Study Start Date: | April 2008 |
| Estimated Study Completion Date: | February 2010 |
| Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1
testim
|
Drug: Testim
50 mg/dose7day
Other Name: testosteron
|
|
Experimental: 2
placebo
|
Drug: placebo
placebo
Other Name: gel
|
|
Experimental: 3
training
|
Behavioral: Strength training
three times a week
Other Name: training
|
Detailed Description:
The effect of testim and training in hypogonadal men.
Eligibility| Ages Eligible for Study: | 65 Years to 78 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Male 65-78
- Bioavailable testosterone < 7.3 nmol/L
- Waist > 94 cm
Exclusion Criteria:
- Haematocrit > 0.50
- Known c. prostate or PSA > 3 Myg/L
- Known malignant disease
- Alcohol or drug abuse
- BMI > 40 kg/m2
- Use of 5 alpha reductance inhibitors
- Plan to father children
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Marianne Andersen, Odense University Hospital |
| ClinicalTrials.gov Identifier: | NCT00700024 History of Changes |
| Other Study ID Numbers: | 030 |
| Study First Received: | June 16, 2008 |
| Last Updated: | September 18, 2009 |
| Health Authority: | Denmark: Danish Dataprotection Agency Denmark: Danish Medicines Agency Denmark: Ethics Committee Denmark: National Board of Health |
Keywords provided by Odense University Hospital:
|
Body composition Physical activity Metabolic syndrome |
Additional relevant MeSH terms:
|
Hypogonadism Metabolic Syndrome X Gonadal Disorders Endocrine System Diseases Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases Methyltestosterone Testosterone 17 beta-cypionate Testosterone |
Testosterone enanthate Testosterone undecanoate Antineoplastic Agents, Hormonal Antineoplastic Agents Therapeutic Uses Pharmacologic Actions Anabolic Agents Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Androgens |
ClinicalTrials.gov processed this record on May 16, 2013